已收盤 09-05 16:00:00 美东时间
+2.340
+12.62%
绩优股狂飙!梅西百货大涨超20%,REV Group涨超12%;房地美ADR涨超16%,美参议院议员敦促特朗普政府暂缓出售公司股份>>
09-04 17:12
SAN DIEGO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Beam Global announced the renewal of its Multiple Award Schedule (MAS) contract with the U.S. General Services Administration (GSA) through October 31, 2030, with options to extend until 2040. Beam Global's offerings have been added to Special Item Number (SIN) 334512, enabling state and local governments to purchase its products through the GSA MAS program, streamlining procurement processes and elimi...
08-26 10:00
Beam Therapeutics's (NYSE:BEAM) short percent of float has risen 4.04% since it...
08-25 22:01
Beam Therapeutics Inc. announced that its management will participate in fireside chats at three upcoming investor conferences: Citi’s 2025 Biopharma Back to School Conference on September 3, 2025, Wells Fargo Healthcare Conference on September 4, 2025, and H.C. Wainwright’s 27th Global Investment Conference on September 8, 2025. Live webcasts will be available on the company’s website, www.beamtx.com, and archived for 60 days. Beam Therapeutics ...
08-25 11:00
Beamr Imaging Ltd. (NASDAQ: BMR), a leading video optimization company, will present virtually at the H.C. Wainwright 27th Annual Global Investment Conference in New York on September 8-11, 2025. Investors and professionals can register and schedule one-on-one meetings on September 11. Beamr’s on-demand presentation will be available on the conference website from September 5, 2025, until December 4, 2025. The company, trusted by Netflix and Para...
08-21 11:00
由“木头姐”伍德管理的ARK创新ETF今年以来表现亮眼,但近期资金流向显示投资者可能在获利了结
08-20 06:00
Ark Invest, led by Cathie Wood, made significant trades on Monday, acquiring shares of Robinhood and Deere & Co. Other key trades also took place.
08-19 09:41
Flexible Exchange Options, or “Flex” contracts, are emerging as a key tool behind the rapid rise of defined-outcome ETFs, giving asset managers the ability to customize strike prices and expirations r...
08-17 23:23
Pfizer's Phase 3 trial of inclacumab in sickle cell disease misses its main goal but shows safety, with further updates on other drugs planned.
08-16 03:35
Beam Global will report Q2 2025 results on August 14, 2025 after market close. A conference call at 4:30 p.m. ET will discuss financials and updates. Pre-registration required via provided link._call sterng:Beam Global to release Q2 2025 results on August 14, 2025, followed by a conference call at 4:30 p.m. ET. Pre-register through the link for access.
08-11 10:00